Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2551
GraniteShares 2x Long PLTR Daily ETF
PTIR
$440M
| $570K | ﹤0.01% |
+34,800
| New | +$663K |
2026 Q1
0 quarters
|
|
2552
Neuraxis
NRXS
$87M
| $569K | ﹤0.01% |
+76,954
| New | +$421K |
2026 Q1
0 quarters
|
|
2553
Mammoth Energy Services
TUSK
$136M
| $568K | ﹤0.01% |
231,972
+45,900
| +25% | +$104K |
2020 Q2
23 quarters
|
|
2554
Corebridge Financial
CRBG
$15.2B
| $565K | ﹤0.01% |
23,700
-574,200
| -96% | -$16.1M |
2025 Q3
2 quarters
|
|
2555
Eightco Holdings
ORBS
$361M
| $565K | ﹤0.01% |
605,702
-43,398
| -7% | -$55.5K |
2025 Q4
1 quarter
|
|
2556
Hyliion Holdings
HYLN
$686M
| $561K | ﹤0.01% |
318,600
+104,500
| +49% | +$210K |
2021 Q4
17 quarters
|
|
2557
Coherus Oncology
CHRS
$165M
| $561K | ﹤0.01% |
331,700
+193,800
| +141% | +$344K |
2025 Q1
4 quarters
|
|
2558
Upstream Bio Inc
UPB
$257M
| $559K | ﹤0.01% |
62,100
+45,700
| +279% | +$822K |
2025 Q4
1 quarter
|
|
2559
JPMorgan Equity Premium Income ETF
JEPI
$45.8B
| $557K | ﹤0.01% |
9,835
-60,765
| -86% | -$3.54M |
2025 Q3
2 quarters
|
|
2560
Jiayin Group
JFIN
$70.1M
| $554K | ﹤0.01% |
132,300
+12,300
| +10% | +$77.4K |
2023 Q3
10 quarters
|
|
2561
Filana Therapeutics
FLNA
$39.5M
| $552K | ﹤0.01% |
+326,759
| New | +$673K |
2026 Q1
0 quarters
|
|
2562
Xtant Medical Holdings
XTNT
$45.7M
| $551K | ﹤0.01% |
987,410
+67,550
| +7% | +$41.6K |
2017 Q3
34 quarters
|
|
2563
Manitowoc
MTW
$781M
| $550K | ﹤0.01% |
47,244
-63,956
| -58% | -$858K |
2025 Q3
2 quarters
|
|
2564
JPMorgan Active Growth ETF
JGRO
$10.3B
| $549K | ﹤0.01% |
6,500
-13,300
| -67% | -$1.19M |
2024 Q2
7 quarters
|
|
2565
Arqit Quantum
ARQQ
$300M
| $549K | ﹤0.01% |
+41,400
| New | +$779K |
2026 Q1
0 quarters
|
|
2566
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.68B
| $548K | ﹤0.01% |
13,800
+6,300
| +84% | +$253K |
2023 Q4
9 quarters
|
|
2567
Defiance Daily Target 2x Long MSTR ETF
MSTX
$341M
| $547K | ﹤0.01% |
+28,000
| New | +$840K |
2026 Q1
0 quarters
|
|
2568
Chimera Investment
CIM
$750M
| $545K | ﹤0.01% |
+43,453
| New | +$567K |
2026 Q1
0 quarters
|
|
2569
Acuity Brands
AYI
$8.93B
| $544K | ﹤0.01% |
1,940
-7,160
| -79% | -$2.18M |
2018 Q4
29 quarters
|
|
2570
American Vanguard Corp
AVD
$47.2M
| $544K | ﹤0.01% |
218,300
+54,800
| +34% | +$233K |
2023 Q1
12 quarters
|
|
2571
Minerva Neurosciences
NERV
$152M
| $540K | ﹤0.01% |
89,700
-59,500
| -40% | -$341K |
2016 Q1
40 quarters
|
|
2572
Teucrium 2x Long Daily XRP ETF
XXRP
$137M
| $538K | ﹤0.01% |
14,010
+10,490
| +298% | +$705K |
2025 Q4
1 quarter
|
|
2573
Silicom
SILC
$339M
| $537K | ﹤0.01% |
+25,437
| New | +$471K |
2026 Q1
0 quarters
|
|
2574
Nortech Systems
NSYS
$32.4M
| $536K | ﹤0.01% |
43,999
-400
| -0.9% | -$3.66K |
2015 Q1
44 quarters
|
|
2575
Scully Royalty
SRL
$77.7M
| $533K | ﹤0.01% |
68,114
+19,800
| +41% | +$170K |
2013 Q2
51 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.